The grades of 12 Health Care Equipment & Supplies stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Intuitive Surgical, Inc. (ISRG) improves from a B to a A rating this week. Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci Surgical Systems, EndoWrist instruments, and surgical accessories. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of ISRG stock.
This week, C. R. Bard, Inc.’s (BCR) ratings are up from a B last week to a A. C. R. Bard, Inc. is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The company also gets A’s in return on equity. For more information, get Portfolio Grader’s complete analysis of BCR stock.
This is a strong week for Sirona Dental Systems, Inc. (SIRO). The company’s rating climbs to A from the previous week’s B. Sirona Dental Systems, Inc. is a manufacturer of high-quality, technologically-advanced dental equipment, and is focused on developing, manufacturing and marketing innovative solutions for dentists around the world. For more information, get Portfolio Grader’s complete analysis of SIRO stock.
Stryker Corporation (SYK) is seeing ratings go up from a B last week to a A this week. Stryker Corporation produces a variety of products in the medical technology sector. The company also gets A’s in operating margin growth, earnings growth, and return on equity. For more information, get Portfolio Grader’s complete analysis of SYK stock.
West Pharmaceutical Services, Inc. (WST) boosts its rating from a B to a A this week. West Pharmaceutical Services, Inc. is a manufacturer of components and systems for injectable drug delivery, and plastic packaging and delivery system components for the healthcare and consumer products industries. For more information, get Portfolio Grader’s complete analysis of WST stock.
Anika Therapeutics, Inc. (ANIK) earns a A this week, jumping up from last week’s grade of B. Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. The company also gets A’s in earnings revisions, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of ANIK stock.
Vascular Solutions, Inc. (VASC) gets a higher grade this week, advancing from a C last week to a B. Vascular Solutions, Inc. is a medical device company focused on bringing clinically advanced solutions to interventional cardiologists and interventional radiologists worldwide. The company also gets A’s in earnings surprise. For more information, get Portfolio Grader’s complete analysis of VASC stock.
Merit Medical Systems, Inc.’s (MMSI) ratings are looking better this week, moving up to a B from last week’s C. Merit Medical Systems, Inc. is engaged in the development, manufacture, and marketing of disposable medical products that are used primarily in diagnostic and interventional cardiology and radiology procedures. For more information, get Portfolio Grader’s complete analysis of MMSI stock.
This week, Cutera, Inc. (CUTR) pushes up from a C to a B rating. Cutera, Inc. is a global provider of laser and other light-based aesthetic systems for practitioners worldwide. The company also gets A’s in sales growth, earnings revisions, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of CUTR stock.
The rating of OraSure Technologies, Inc. (OSUR) moves up this week, rising from a C to a B. OraSure Technologies, Inc. develops, manufactures, and markets medical devices and diagnostic products. The company also gets A’s in earnings growth, earnings revisions, and earnings surprise. For more information, get Portfolio Grader’s complete analysis of OSUR stock.
Cerus Corporation (CERS) shows solid improvement this week. The company’s rating rises from a C to a B. Cerus Corporation is a biomedical products company engaged in the development and commercialization of the INTERCEPT Blood System. For more information, get Portfolio Grader’s complete analysis of CERS stock.
Xtant Medical Holdings, Inc. (XTNT) gets a higher grade this week, advancing from a C last week to a B. The company also gets A’s in sales growth and earnings surprise. For more information, get Portfolio Grader’s complete analysis of XTNT stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
